Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2006-10-03
2006-10-03
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S317000, C514S262100
Reexamination Certificate
active
07115740
ABSTRACT:
Disclosed are novel pyrimido compounds that are selective inhibitors of both KDR and FGFR kinases. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and methods of treating cancer.
REFERENCES:
patent: 2949466 (1960-08-01), Hoefle et al.
patent: 3939084 (1976-02-01), Sullivan
patent: 4425346 (1984-01-01), Horlington
patent: 4886807 (1989-12-01), Kitamura et al.
patent: 6150373 (2000-11-01), Harris et al.
patent: 6451804 (2002-09-01), Dunn et al.
patent: 2004/0019210 (2004-01-01), Connolly et al.
patent: 2004/0097485 (2004-05-01), Burkitt et al.
patent: WO 98/24432 (1998-06-01), None
patent: WO 99/61444 (1999-12-01), None
patent: WO 00/24744 (2000-05-01), None
patent: WO 01/29041 (2001-04-01), None
patent: WO 01/29042 (2001-04-01), None
patent: WO 01/64679 (2001-09-01), None
patent: WO 02/18380 (2002-03-01), None
patent: WO 03/062236 (2003-07-01), None
Draetta, G. and Pagano, M. in “Annual Reports in Medicinal Chemistry, vol. 31”, 1996, Academic Press, San Diego, p. 241-246.
Noble, M.E.M. et al, Science, vol. 303, 2004, pp. 1800-1805.
Anderson, M.R. et al, Expert Opin. Investig. Drugs, 2003, 12(4) 577-592.
Laird, A.D. et al, Expert opin. Investig. Drugs, 2003, 12(1), 51-64.
Traxler, Peter, Expert Opin. Ther. Targets, 2003, 7(2) 215-234.
Boschelli, et al.,Drugs of the Future, 200025(7) pp. 717-736.
Alexander J. et al.,J. Med. Chem. 1988, vol. 31, pp. 318-322.
Masquelin et al.,Helvetica Chimica Acta,vol. 81 (1998) pp. 646-659.
Devi et al.,Indian Journal of Heterocyclic Chemistry,vol. 7, Jan.-Mar. 1998, pp. 193-196.
Tominaga et al.,Chemical&Pharmaceutical Bulletin, vol. 32, No. 1, Jan. 1984, pp. 122-129.
Tominaga et al.,Heterocycles,vol. 12, No. 4. 1979, pp. 503-504.
Marsh, et al.,Chemical Communications,1996, pp. 1527-1528.
Z. Chem. 20Jg (1980) Heft. 11, pp. 412-413.
Cappuccino et al.,Cancer Research,vol. 24, Aug. 1964, pp. 1243-1248.
Chatterjee et al.,J. Sci. Industr. Res.,vol. 17B, Feb. 1958, pp. 63-70.
Chatterjee et al.,J. Sci. Industr. Res.,vol. 18B, Jul. 1959, pp. 272-278.
Graboyes et al.,Pteridines X.,vol. 11 Jan. 6, 1968, pp. 568-573.
Grohe et al.,Liebigs Ann. Chem.,1974, pp. 2066-2073.
Gulevskaya et al.,Chemistry of Heterocyclic Compounds,vol. 30, No. 9, 1994, pp. 1083-1091.
Hirota et al.,J. Chem. Soc. Perkin Trans. 1,1990, pp. 123-128.
Srivastava et al.,Combinatorial Chemistry&High Throughout Screening,1999, 2, pp. 33-37.
Taylor,Pyrimido [4,5-D]Pyrimidines,vol. 82, pp. 5711-5718.
Wamhoff et al.,Heterocycles,vol. 35, No. 2, 1993, pp. 1055-1066.
Hirota, M. et al. “A Facile Synthesis of 7-Substituted Pyrimido[4,5-d]-Pyrimidine-2, 4-diones”, Synthesis,pp. 589-590 (1984).
Chen Yi
Dermatakis Apostolos
Liu Jin-Jun
Luk Kin-Chun
Michoud Christophe
Hoffmann-la Roche Inc.
Johnston George W.
McKenzie Thomas C.
Rocha-Tramaloni Patricia S.
LandOfFree
Pyrimido compounds having antiproliferative activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimido compounds having antiproliferative activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimido compounds having antiproliferative activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647442